PharmTech News

Jan 22, 2018
By Pharmaceutical Technology Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 19, 2018
By Pharmaceutical Technology Editors
GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.
Jan 19, 2018
By Pharmaceutical Technology Editors
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
Jan 19, 2018
By Pharmaceutical Technology Editors
Lonza Pharma & Biotech's's Modular Automated Sampling Technology (MAST) platform, which allows for the collection of up to 10 sterile sample sources for automated analysis in multiple analytical devices, won the CPhI Pharma Award 2017 for Excellence in Pharma: Bioprocessing.
Jan 19, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
1CryoBio’s Flexiquot technology allows for the deep-freeze storage and handling of multiple aliquots in a single tube, winning it the CPhI Pharma Award 2017 for Excellence in Pharma: Analysis, Testing, and Quality Control.
Jan 18, 2018
By Pharmaceutical Technology Editors
The company is developing a pipeline of combination therapies using its patented polymer-based matrix delivery system, known as TAOS (targeted orchestrated signalling matrix).
Jan 18, 2018
By Pharmaceutical Technology Editors
Researchers at Purdue University and industry experts have partnered up at the Advanced Lyophilization Technology Hub to optimize the 70-year-old freeze-drying process.
Jan 18, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The NGC Fraction Collector from Bio-Rad Laboratories allows researchers to choose how to collect and when to access their fractions for analytical or preparative chromatography applications.
Jan 17, 2018
By Pharmaceutical Technology Editors
The company has expanded its voluntary nationwide recall to include a second lot of Nexterone injection. This recall is due to particulate matter found in the product.
Jan 16, 2018
By Pharmaceutical Technology Editors
A ceremony was held at Cambrex’s Karlskoga facility to mark the commencement of a long-term manufacturing agreement with AstraZeneca for a key intermediate.
native1_300x100
lorem ipsum